263 related articles for article (PubMed ID: 26911390)
21. An investigation of the effects of FGFR2 and B7-H4 polymorphisms in breast cancer.
Ozgöz A; Samli H; Oztürk KH; Orhan B; Icduygu FM; Aktepe F; Imirzalioglu N
J Cancer Res Ther; 2013; 9(3):370-5. PubMed ID: 24125968
[TBL] [Abstract][Full Text] [Related]
22. Association between breast cancer susceptibility loci and mammographic density: the Multiethnic Cohort.
Woolcott CG; Maskarinec G; Haiman CA; Verheus M; Pagano IS; Le Marchand L; Henderson BE; Kolonel LN
Breast Cancer Res; 2009; 11(1):R10. PubMed ID: 19232126
[TBL] [Abstract][Full Text] [Related]
23. Determination of
Uloza V; Tamauskaite T; Vilkeviciute A; Pasvenskaite A; Liutkevicius V; Liutkeviciene R
Dis Markers; 2019; 2019():3907232. PubMed ID: 31781300
[TBL] [Abstract][Full Text] [Related]
24. Tendencies of FGFR2 rs2981582 polymorphism in patients with oral cancer.
Liutkevicius V; Tamauskaite T; Vilkeviciute A; Liutkeviciene R; Smalinskaite R; Giedraitiene A; Smalinskiene A; Uloza V
Stomatologija; 2020; 22(1):3-8. PubMed ID: 32706340
[TBL] [Abstract][Full Text] [Related]
25. [Associations between TOX3 rs3803662 polymorphisms and immunological markers of breast cancer].
Chen Q; He Y; Liu C; Liu H; Sun X; Shao Y; Huang T; Xu B
Zhonghua Yi Xue Za Zhi; 2015 Sep; 95(34):2783-6. PubMed ID: 26711978
[TBL] [Abstract][Full Text] [Related]
26. The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes.
Bayraktar S; Thompson PA; Yoo SY; Do KA; Sahin AA; Arun BK; Bondy ML; Brewster AM
Oncologist; 2013; 18(5):493-500. PubMed ID: 23635555
[TBL] [Abstract][Full Text] [Related]
27. Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases.
Huijts PE; Vreeswijk MP; Kroeze-Jansema KH; Jacobi CE; Seynaeve C; Krol-Warmerdam EM; Wijers-Koster PM; Blom JC; Pooley KA; Klijn JG; Tollenaar RA; Devilee P; van Asperen CJ
Breast Cancer Res; 2007; 9(6):R78. PubMed ID: 17997823
[TBL] [Abstract][Full Text] [Related]
28. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.
Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H
Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278
[TBL] [Abstract][Full Text] [Related]
29. The breast cancer susceptibility-related polymorphisms at the TOX3/LOC643714 locus associated with lung cancer risk in a Han Chinese population.
Jiang C; Yu S; Qian P; Guo R; Zhang R; Ao Z; Li Q; Wu G; Chen Y; Li J; Wang C; Yao W; Xu J; Qian G; Ji F
Oncotarget; 2016 Sep; 7(37):59742-59753. PubMed ID: 27486757
[TBL] [Abstract][Full Text] [Related]
30. Association of single nucleotide polymorphisms in FGF-RAS/MAP signalling cascade with breast cancer susceptibility.
Dankova Z; Zubor P; Grendar M; Kapinova A; Zelinova K; Jagelkova M; Gondova A; Dokus K; Kalman M; Lasabova Z; Danko J
Gen Physiol Biophys; 2017 Dec; 36(5):565-572. PubMed ID: 29372690
[TBL] [Abstract][Full Text] [Related]
31. Risk of aggressive breast cancer in women of Han nationality carrying TGFB1 rs1982073 C allele and FGFR2 rs1219648 G allele in North China.
Chen XH; Li XQ; Chen Y; Feng YM
Breast Cancer Res Treat; 2011 Jan; 125(2):575-82. PubMed ID: 20640597
[TBL] [Abstract][Full Text] [Related]
32. Genetic predisposition, parity, age at first childbirth and risk for breast cancer.
Butt S; Harlid S; Borgquist S; Ivarsson M; Landberg G; Dillner J; Carlson J; Manjer J
BMC Res Notes; 2012 Aug; 5():414. PubMed ID: 22867275
[TBL] [Abstract][Full Text] [Related]
33. Genetic variants of fibroblast growth factor receptor 2 (FGFR2) are associated with breast cancer risk in Chinese women of the Han nationality.
Chen F; Lu M; Xue Y; Zhou J; Hu F; Chen X; Zhao Z; Li Y; Wang X
Immunogenetics; 2012 Jan; 64(1):71-6. PubMed ID: 21822685
[TBL] [Abstract][Full Text] [Related]
34. Two polymorphisms, rs2046210 and rs3803662, are associated with breast cancer risk in a Vietnamese case-control cohort.
Thanh NTN; Lan NTT; Phat PT; Giang NDT; Hue NT
Genes Genet Syst; 2018 Oct; 93(3):101-109. PubMed ID: 30078824
[TBL] [Abstract][Full Text] [Related]
35. A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India.
Siddiqui S; Chattopadhyay S; Akhtar MS; Najm MZ; Deo SV; Shukla NK; Husain SA
PLoS One; 2014; 9(10):e110426. PubMed ID: 25333473
[TBL] [Abstract][Full Text] [Related]
36.
Zhu B; Wang J; Qin L; Wang L; Zheng Y; Zhang L; Wang W
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30206133
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the contribution of cyclooxygenase 2 genotypes to breast cancer in Taiwan.
Su CH; Hsiao CL; Chang WS; Liu LC; Wang HC; Tsai CW; Li LY; Tsai CH; Bau DT
Anticancer Res; 2014 Nov; 34(11):6711-6. PubMed ID: 25368279
[TBL] [Abstract][Full Text] [Related]
38. Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study.
Travis RC; Reeves GK; Green J; Bull D; Tipper SJ; Baker K; Beral V; Peto R; Bell J; Zelenika D; Lathrop M;
Lancet; 2010 Jun; 375(9732):2143-51. PubMed ID: 20605201
[TBL] [Abstract][Full Text] [Related]
39. Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.
Özgöz A; İçduygu FM; Yükseltürk A; ŞamlI H; Öztürk KH; Başkan Z
J Genet; 2020; 99():. PubMed ID: 32366738
[TBL] [Abstract][Full Text] [Related]
40. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
